The cardiac valve market size was over USD 14.4 billion in 2025 and is anticipated to exceed USD 43.9 billion by the end of 2035, growing at over 11.8% CAGR during the forecast period i.e., between 2026-2035. North America industry is expected to hold the largest share of 42.3% by the end of 2035, owing to the region’s early adoption of cutting-edge transcatheter technologies and a strong presence of leading device manufacturers.